Celcuity Long Term Deferred Charges (Quarterly) Analysis

Celcuity, Inc. (CELC)

109.17 +4.15 (+3.95%) USD | NASDAQ | Jan 07, 16:00

108.00 -1.17 (-1.07%) After-Hours: 20:00

View Long Term Deferred Charges (Quarterly) for CELC.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Long Term Deferred Charges (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Long Term Deferred Charges (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Long Term Deferred Charges (Quarterly) Benchmarks

Start Trial

Olema Pharmaceuticals, Inc.	--
Replimune Group, Inc.	--
Arrowhead Pharmaceuticals, Inc.	--
Cidara Therapeutics, Inc.	--
Cogent Biosciences, Inc.	--